Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 01, 2024

SELL
$209.01 - $232.56 $668,832 - $744,192
-3,200 Reduced 78.05%
900 $196,000
Q4 2023

Feb 12, 2024

BUY
$197.69 - $227.29 $454,687 - $522,767
2,300 Added 127.78%
4,100 $931,000
Q3 2023

Nov 13, 2023

SELL
$201.05 - $221.7 $140,735 - $155,190
-700 Reduced 28.0%
1,800 $361,000
Q2 2023

Aug 10, 2023

BUY
$211.93 - $241.33 $42,386 - $48,266
200 Added 8.7%
2,500 $603,000
Q1 2023

May 09, 2023

SELL
$213.32 - $257.83 $170,656 - $206,264
-800 Reduced 25.81%
2,300 $527,000
Q4 2022

Feb 10, 2023

BUY
$203.72 - $248.97 $81,488 - $99,588
400 Added 14.81%
3,100 $729,000
Q3 2022

Nov 10, 2022

BUY
$204.81 - $262.19 $122,886 - $157,314
600 Added 28.57%
2,700 $553,000
Q2 2022

Aug 15, 2022

SELL
$213.86 - $277.87 $256,632 - $333,444
-1,200 Reduced 36.36%
2,100 $492,000
Q1 2022

May 13, 2022

SELL
$259.82 - $298.18 $1.38 Million - $1.58 Million
-5,300 Reduced 61.63%
3,300 $870,000
Q4 2021

Feb 11, 2022

SELL
$271.6 - $314.21 $869,120 - $1.01 Million
-3,200 Reduced 27.12%
8,600 $2.7 Million
Q3 2021

Nov 15, 2021

BUY
$274.82 - $308.34 $742,014 - $832,517
2,700 Added 29.67%
11,800 $3.32 Million
Q2 2021

Aug 16, 2021

SELL
$251.87 - $278.14 $881,545 - $973,490
-3,500 Reduced 27.78%
9,100 $2.51 Million
Q1 2021

May 17, 2021

BUY
$204.88 - $255.03 $1.95 Million - $2.42 Million
9,500 Added 306.45%
12,600 $3.21 Million
Q4 2020

Feb 16, 2021

BUY
$186.91 - $214.42 $579,421 - $664,702
3,100 New
3,100 $631,000
Q3 2020

Nov 16, 2020

SELL
$167.03 - $201.3 $167,030 - $201,300
-1,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$113.31 - $182.44 $113,310 - $182,440
1,000 New
1,000 $166,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $18.3B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.